Wednesday, November 11, 08:38 am IST
Hot Searches:  SEBInokia chargerhome loan rates
| Feedback
Not dependent on SALUTAS any more: DRL
Published on Tue, May 20, 2008 at 17:57   |  Updated at Tue, May 20, 2008 at 19:33  |  Source : CNBC-TV18

Dr Reddys Laboratories has announced its fourth quarter results. The company's Q4 consolidated net profit was at Rs 103 crore versus 325.5 crore (US GAAP).

 


Its Q4 consolidated net sales were at Rs 1,320 crore versus Rs 1,557.3 crore(US GAAP).

 

The company's FY08 consolidated net profit stood at Rs 470 crore. DRL Q4FY07 numbers included Zofran Exclusivity (Rs 270 crore).

GV Prasad, Vice Chairman and CEO, Dr Reddy's Labs said it is not dependent on SALUTAS any more, reports CNBC-TV18. "We will see improvement in the coming quarters. The Custom Pharmaceutical Services, or CPS, , which involves making drugs and ingredients specifically for other companies, business saw a de-growth because of the supply situation in Mexico," it added.

 

Reditux launched in India and is showing good growth, the management added.

 

For complete conference, watch video...

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
©Network 18, 2009. All Rights Reserved